Literature DB >> 15829701

Suppressors of cytokine signaling regulate angiotensin II-activated Janus kinase-signal transducers and activators of transcription pathway in renal cells.

Purificación Hernández-Vargas1, Oscar López-Franco, Guillermo Sanjuán, Mónica Rupérez, Guadalupe Ortiz-Muñoz, Yusuke Suzuki, Pablo Aguado-Roncero, Gloria Pérez-Tejerizo, Julia Blanco, Jesús Egido, Marta Ruiz-Ortega, Carmen Gómez-Guerrero.   

Abstract

Suppressors of cytokine signaling (SOCS) family is constituted by cytokine-inducible proteins that modulate receptor signal transduction via tyrosine kinases, mainly the Janus kinase-signal transducers and activators of transcription (JAK-STAT) pathway. Differential SOCS expression was noted in renal cells that were incubated with inflammatory stimuli, but the role of SOCS in the pathogenesis of renal diseases is not yet well defined. Because angiotensin II (Ang II) plays a key role in renal disease, SOCS proteins were studied as a novel mechanism involved in the negative regulation of Ang II-mediated processes. Systemic Ang II infusion for 3 d increased the renal mRNA expression of SOCS-3 and SOCS-1. SOCS protein synthesis was found in glomerular mesangial area and tubules. In cultured mesangial cells and tubular epithelial cells, Ang II induced a rapid and transient SOCS-3 and SOCS-1 expression in parallel with JAK2 and STAT1 activation. In both cell types, overexpression of SOCS proteins prevented the STAT activation in response to Ang II. SOCS expression observed in Ang II-infused rats and in Ang II-stimulated cells was significantly inhibited by treatment with AT(1) but not AT(2) receptor antagonist and was attenuated in mesangial cells from AT(1a)-deficient mice, demonstrating the implication of AT(1) in those responses. In SOCS-3 knockdown studies, antisense oligonucleotides inhibited the expression of SOCS-3 and increased the Ang II-induced STAT activation and c-Fos/c-Jun expression, then resulting in a more severe renal damage. These results suggest that SOCS proteins may act as negative regulators of Ang II signaling in renal cells and implicate SOCS as important modulators of renal damage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15829701     DOI: 10.1681/ASN.2004050374

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  16 in total

1.  Therapeutic effects of suppressors of cytokine signaling in diabetic nephropathy.

Authors:  Qingjuan Liu; Lingling Xing; Lei Wang; Fang Yao; Shuxia Liu; Jun Hao; Wei Liu; Huijun Duan
Journal:  J Histochem Cytochem       Date:  2013-11-11       Impact factor: 2.479

2.  Loss of STAT1 is associated with increased aortic rupture in an experimental model of aortic dissection and aneurysm formation.

Authors:  Matthew J Eagleton; Jun Xu; Mingfang Liao; Brittney Parine; Guy M Chisolm; Linda M Graham
Journal:  J Vasc Surg       Date:  2010-04       Impact factor: 4.268

3.  Suppressor of Cytokine Signaling-1 Peptidomimetic Limits Progression of Diabetic Nephropathy.

Authors:  Carlota Recio; Iolanda Lazaro; Ainhoa Oguiza; Laura Lopez-Sanz; Susana Bernal; Julia Blanco; Jesus Egido; Carmen Gomez-Guerrero
Journal:  J Am Soc Nephrol       Date:  2016-09-08       Impact factor: 10.121

4.  Stat3 Controls Tubulointerstitial Communication during CKD.

Authors:  Frank Bienaimé; Mordi Muorah; Lucie Yammine; Martine Burtin; Clément Nguyen; Willian Baron; Serge Garbay; Amandine Viau; Mélanie Broueilh; Thomas Blanc; Dorien Peters; Valeria Poli; Dany Anglicheau; Gérard Friedlander; Marco Pontoglio; Morgan Gallazzini; Fabiola Terzi
Journal:  J Am Soc Nephrol       Date:  2016-05-06       Impact factor: 10.121

5.  Suppressors of cytokine signaling abrogate diabetic nephropathy.

Authors:  Guadalupe Ortiz-Muñoz; Virginia Lopez-Parra; Oscar Lopez-Franco; Paula Fernandez-Vizarra; Beñat Mallavia; Claudio Flores; Ana Sanz; Julia Blanco; Sergio Mezzano; Alberto Ortiz; Jesus Egido; Carmen Gomez-Guerrero
Journal:  J Am Soc Nephrol       Date:  2010-02-25       Impact factor: 10.121

Review 6.  Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney.

Authors:  Volker Vallon; Scott C Thomson
Journal:  Annu Rev Physiol       Date:  2012       Impact factor: 19.318

7.  Peptide-based inhibition of IκB kinase/nuclear factor-κB pathway protects against diabetes-associated nephropathy and atherosclerosis in a mouse model of type 1 diabetes.

Authors:  Ainhoa Oguiza; Carlota Recio; Iolanda Lazaro; Beñat Mallavia; Julia Blanco; Jesus Egido; Carmen Gomez-Guerrero
Journal:  Diabetologia       Date:  2015-04-28       Impact factor: 10.122

Review 8.  Twenty years after ACEIs and ARBs: emerging treatment strategies for diabetic nephropathy.

Authors:  Stacy A Johnson; Robert F Spurney
Journal:  Am J Physiol Renal Physiol       Date:  2015-09-02

9.  Amelioration of crescentic glomerulonephritis by RhoA kinase inhibitor, Fasudil, through podocyte protection and prevention of leukocyte migration.

Authors:  Teruo Hidaka; Yusuke Suzuki; Michifumi Yamashita; Terumi Shibata; Yuichi Tanaka; Satoshi Horikoshi; Yasuhiko Tomino
Journal:  Am J Pathol       Date:  2008-02-02       Impact factor: 4.307

Review 10.  JAK-STAT and the renin-angiotensin system: The role of the JAK-STAT pathway in blood pressure and intrarenal renin-angiotensin system regulation.

Authors:  Ryousuke Satou; Romer A Gonzalez-Villalobos
Journal:  JAKSTAT       Date:  2012-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.